Telomere Peptide

Epitalon

Telomerase-activating peptide with intriguing but unvalidated anti-aging claims.

Telomerase (hTERT)Pineal melatonin synthesisp53/Rb cell cycle regulation

31 D

Evidence Score

ⓘ For informational purposes only — not medical advice.

Score Breakdown

Overview

Epitalon (epithalon, epithalone) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied primarily by Russian researcher Vladimir Khavinson. It is proposed to activate telomerase, potentially extending telomere length and cellular lifespan. Published data is limited to a small number of Russian-language studies and cell culture experiments.

Mechanism of Action

Epitalon is proposed to activate telomerase reverse transcriptase (hTERT) expression, enabling telomere elongation. Secondary mechanisms include stimulation of pineal gland melatonin production and modulation of cell cycle regulators. The molecular mechanism of telomerase activation by a four-amino-acid peptide is not well-characterized.

Evidence Base

A small number of studies, primarily from Khavinson's research group at the St. Petersburg Institute of Bioregulation and Gerontology, report telomere elongation and lifespan extension in animal models. One human observational study reported improved health outcomes in elderly subjects. No Western peer-reviewed RCTs exist.

Gene Pathway Detail

The proposed hTERT activation is the primary gene target, but the mechanism by which a small synthetic peptide reaches the nucleus and activates telomerase gene expression is not clearly established. Biomeme monitoring of hTERT expression could provide data, but baseline expectations for gene expression changes in human users are undefined.

mRNA Monitoring Insight

hTERT gene expression is monitorable, but without established human response benchmarks, interpreting mRNA data for epitalon is speculative. Biomeme's platform could help establish baseline human molecular data for this peptide.

Safety Considerations

Very limited safety data. Telomerase activation carries theoretical cancer risk (telomerase is upregulated in ~90% of cancers). No FDA evaluation. Quality control of commercially available epitalon is variable.

FAQ

Could epitalon cause cancer by activating telomerase?

This is a legitimate theoretical concern. Telomerase activation is a hallmark of cancer biology. Without controlled human safety data, this risk cannot be quantified. The D grade reflects the significant evidence gaps.

Quick Facts

Category: Telomere Peptide
Score: 31/100 (D)
Gene Pathways: 3 characterized

Sources

[1] Khavinson — Peptide Bioregulation of Aging

Compare Others

Monitor Your Peptide Response.

Biomeme's transcriptomic platform tracks molecular pathway engagement so you know if your therapy is working.